ACSL4 and allergic disease: Collectively, ACSL4-dependent ferroptosis in alveolar epithelial type II cells facilitates Bet v 1-induced TH2/TH17-related inflammatory and epithelial damage, orchestrating allergic disease and being capable of acting as an intervention target for allergy therapy.